These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Current and Emerging Pharmacotherapies for Weight Management in Prediabetes and Diabetes. Lau DC; Teoh H Can J Diabetes; 2015 Dec; 39 Suppl 5():S134-41. PubMed ID: 26654857 [TBL] [Abstract][Full Text] [Related]
3. Current and Emerging Pharmacotherapies for Type 2 Diabetes. Lau DC Can J Diabetes; 2015 Dec; 39 Suppl 5():S127-8. PubMed ID: 26653252 [No Abstract] [Full Text] [Related]
4. Early, aggressive treatment is effective in treating diabetes. Risk of long-term complications reduced significantly. Duke Med Health News; 2012 Sep; 18(9):7. PubMed ID: 23029693 [No Abstract] [Full Text] [Related]
5. 2013 ESC/EASD guidelines on the management of diabetes and cardiovascular disease: established knowledge and evidence gaps. Paneni F Diab Vasc Dis Res; 2014 Jan; 11(1):5-10. PubMed ID: 24254974 [No Abstract] [Full Text] [Related]
6. [Antidiabetic drug therapy in overweight and obese adults with type 2 diabetes]. de Heer J; Parhofer K MMW Fortschr Med; 2013 Apr; 155(7):43-6. PubMed ID: 23668175 [No Abstract] [Full Text] [Related]
7. CONSENSUS STATEMENT BY THE AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY ON THE COMPREHENSIVE TYPE 2 DIABETES MANAGEMENT ALGORITHM--2016 EXECUTIVE SUMMARY. Garber AJ; Abrahamson MJ; Barzilay JI; Blonde L; Bloomgarden ZT; Bush MA; Dagogo-Jack S; DeFronzo RA; Einhorn D; Fonseca VA; Garber JR; Garvey WT; Grunberger G; Handelsman Y; Henry RR; Hirsch IB; Jellinger PS; McGill JB; Mechanick JI; Rosenblit PD; Umpierrez GE; ; Endocr Pract; 2016 Jan; 22(1):84-113. PubMed ID: 26731084 [No Abstract] [Full Text] [Related]
8. Changes in glucose metabolism in people with different glucose metabolism disorders at baseline: follow-up results of a Finnish national diabetes prevention programme. Rautio N; Jokelainen J; Oksa H; Saaristo T; Peltonen M; Puolijoki H; Tuomilehto J; Vanhala M; Moilanen L; Uusitupa M; Keinänen-Kiukaanniemi S Diabet Med; 2015 Dec; 32(12):1611-6. PubMed ID: 25864699 [TBL] [Abstract][Full Text] [Related]
10. Prevention of diabetes and cardiovascular disease among prediabetic individuals: lifestyle versus drug interventions. Hu FB Eur J Cardiovasc Prev Rehabil; 2011 Dec; 18(6):810-2. PubMed ID: 22195302 [No Abstract] [Full Text] [Related]
11. Genetic Predisposition to Weight Loss and Regain With Lifestyle Intervention: Analyses From the Diabetes Prevention Program and the Look AHEAD Randomized Controlled Trials. Papandonatos GD; Pan Q; Pajewski NM; Delahanty LM; Peter I; Erar B; Ahmad S; Harden M; Chen L; Fontanillas P; ; Wagenknecht LE; Kahn SE; Wing RR; Jablonski KA; Huggins GS; Knowler WC; Florez JC; McCaffery JM; Franks PW; Diabetes; 2015 Dec; 64(12):4312-21. PubMed ID: 26253612 [TBL] [Abstract][Full Text] [Related]
12. Risk of diabetes and cardiovascular disease: best to return back to the basics: comment on "Long-term effects of a lifestyle intervention on weight and cardiovascular risk factors in individuals with type 2 diabetes mellitus". Deedwania PC Arch Intern Med; 2010 Sep; 170(17):1575-7. PubMed ID: 20876409 [No Abstract] [Full Text] [Related]
16. What's preventing us from preventing type 2 diabetes? Fradkin JE; Roberts BT; Rodgers GP N Engl J Med; 2012 Sep; 367(13):1177-9. PubMed ID: 23013070 [No Abstract] [Full Text] [Related]
17. Adolescents' views and experiences of treatments for Type 2 diabetes: a qualitative study. Turner KM; Percival J; Dunger DB; Olbers T; Barrett T; Shield JP Diabet Med; 2015 Feb; 32(2):250-6. PubMed ID: 25186101 [TBL] [Abstract][Full Text] [Related]